Detalhe da pesquisa
1.
Selenium speciation studies in cancer patients to evaluate the responses of biomarkers of selenium status to different selenium compounds.
Anal Bioanal Chem
; 416(11): 2835-2848, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38286852
2.
Doxorubicin and cyclophosphamide-induced parotitis: A case report.
J Clin Pharm Ther
; 45(1): 211-213, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31539173
3.
SPAR - a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG clinical trial.
BMC Cancer
; 19(1): 1229, 2019 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31847830
4.
The Interaction of Selenium with Chemotherapy and Radiation on Normal and Malignant Human Mononuclear Blood Cells.
Int J Mol Sci
; 19(10)2018 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30326581
5.
Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial.
Lancet Oncol
; 18(9): 1202-1210, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28729151
6.
Management of rectal cancer in the era of total neoadjuvant therapy and watch and wait: A multidisciplinary team discussion at the Australasian Gastro-Intestinal Trials Group (AGITG) Annual Scientific Meeting 2022.
Asia Pac J Clin Oncol
; 20(1): 71-80, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37340953
7.
PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours.
BMC Cancer
; 12: 496, 2012 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23098625
8.
Development and Validation of a Machine Learning Approach Leveraging Real-World Clinical Narratives as a Predictor of Survival in Advanced Cancer.
JCO Clin Cancer Inform
; 6: e2200064, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36265112
9.
Ethnic Differences in Cancer Rates Among Adults With Type 2 Diabetes in New Zealand From 1994 to 2018.
JAMA Netw Open
; 5(2): e2147171, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35129595
10.
A phase I trial of PR-104, a pre-prodrug of the bioreductive prodrug PR-104A, given weekly to solid tumour patients.
BMC Cancer
; 11: 432, 2011 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21982454
11.
Two cycles of adjuvant carboplatin for clinical stage 1 testicular seminoma in New Zealand centres: A retrospective analysis of efficacy and long-term events.
Cancer Rep (Hoboken)
; 4(2): e1310, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33103860
12.
Comparison of three oral selenium compounds in cancer patients: Evaluation of differential pharmacodynamic effects in normal and malignant cells.
J Trace Elem Med Biol
; 58: 126446, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838377
13.
Long-term Follow-up of Standard-Dose Pembrolizumab Plus Reduced-Dose Ipilimumab in Patients with Advanced Melanoma: KEYNOTE-029 Part 1B.
Clin Cancer Res
; 26(19): 5086-5091, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32605909
14.
Adding selenium to chemotherapy and radiation in haematological malignancies: clinical trials are justified.
Acta Haematol
; 132(2): 254-5, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24903090
15.
Population pharmacokinetic-pharmacodynamic model of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid in cancer patients.
Clin Cancer Res
; 14(7): 2102-10, 2008 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18381951
16.
Comparative Safety and Pharmacokinetic Evaluation of Three Oral Selenium Compounds in Cancer Patients.
Biol Trace Elem Res
; 189(2): 395-404, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30187284
17.
Skin lesions suspicious for melanoma: New Zealand excision margin guidelines in practice.
J Prim Health Care
; 10(3): 210-214, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31039935
18.
Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status.
Cancer Rep (Hoboken)
; 1(1): e1001, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32729235
19.
Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC.
Target Oncol
; 13(1): 89-98, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29188408
20.
5,6-Dimethylxanthenone-4-acetic acid in the treatment of refractory tumors: a phase I safety study of a vascular disrupting agent.
Clin Cancer Res
; 12(6): 1776-84, 2006 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16551862